PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-01-08

Date Title Company
08-Jan-2026 Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs Businesswire
08-Jan-2026 Oncolytics Biotech® Provides Update on Intellectual Property Strategy and Patent Filings Businesswire
08-Jan-2026 One Genomics and CiRA Foundation Announce Strategic Research Collaboration to Advance Precision Genome Engineering Businesswire
08-Jan-2026 RQM+ Appoints Ross D. Segan, MD, MBA, FACS, to Board of Directors Businesswire
08-Jan-2026 Acuitas Therapeutics Expands Collaboration with RNA Technologies & Therapeutics Through Strategic Investment Businesswire
08-Jan-2026 ClostraBio Fully Enrolls Placebo-Controlled Clinical Study of CLB101™, Expands Commercial Reach Through Distribution Partnership with Maypro Businesswire
08-Jan-2026 Sheridan Capital’s Currier Plastics Completes Strategic Acquisitions of Springboard Manufacturing and MOS Plastics Businesswire
08-Jan-2026 MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges Businesswire
08-Jan-2026 Nevada Donor Network Awarded Southern Florida Designated Service Area by CMS Following Competitive National Bid Process ACCESS Newswire
08-Jan-2026 32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics Businesswire
08-Jan-2026 Coya Therapeutics Announces Results of Investigator-Initiated Study of LD IL-2 and CTLA4-Ig Demonstrating Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients Businesswire
08-Jan-2026 Transcat Announces Executive Equity Retention Awards Ahead of CEO Succession in FY2026 Businesswire
08-Jan-2026 858 Therapeutics Announces FDA Fast Track Designation for PARG Inhibitor ETX-19477 for the Treatment of Patients with BRCA-Mutated, Platinum-Resistant Ovarian Cancer Businesswire
08-Jan-2026 Frazier Life Sciences Announces Multiple Promotions to Key Senior Level Positions Businesswire
08-Jan-2026 Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan Businesswire
08-Jan-2026 Epicrispr Reports Early Clinical Activity and Favorable Safety Profile in First-in-Human Epigenetic Editing Study for FSHD Businesswire
08-Jan-2026 Ukko Provides 2026 Strategic Outlook and Highlights Recent Milestones Businesswire
08-Jan-2026 Avenacy Provides Update on Business Progress and Announces 2026 Strategic Priorities Ahead of 44th Annual J.P. Morgan Healthcare Conference Businesswire
08-Jan-2026 JCR Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference Businesswire
08-Jan-2026 INTENT Biologics Receives FDA Fast Track Designation for PEP Biologic™ Businesswire